Back to Search
Start Over
Zephyr AI Presents the Development of a Novel AI-Enabled Composite Biomarker Effective in Predicting Sensitivity to PARP Inhibition in Late-line Cancer Patients
- Source :
- Wireless News. June 7, 2024
- Publication Year :
- 2024
-
Abstract
- Zephyr AI, a healthcare technology company committed to developing AI-Enabled Composite Biomarkers to expand the horizon of precision medicine in cancer drug development, reported it presented a poster at the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Wireless News
- Publication Type :
- News
- Accession number :
- edsgcl.796873438